KPT-330 inhibition of chromosome region maintenance 1 is cytotoxic and sensitizes chronic myeloid leukemia to Imatinib

As tyrosine kinase inhibitors (e.g., Imatinib, IM) fail to induce long-term response in some chronic myeloid leukemia (CML), novel therapies targeting leukemia-dysregulated pathways are necessary. Nuclear-cytoplasmic trafficking of proteins play a key role in the development of leukemia and drug res...

Descripción completa

Detalles Bibliográficos
Autores principales: Nie, Danian, Huang, Kezhi, Yin, Songmei, Li, Yiqing, Xie, Shuangfeng, Ma, Liping, Wang, Xiuju, Wu, Yudan, Xiao, Jie, Wang, Jieyu, Yang, Wenjuan, Liu, Hongyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5913223/
https://www.ncbi.nlm.nih.gov/pubmed/29707241
http://dx.doi.org/10.1038/s41420-018-0049-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5913223/
https://www.ncbi.nlm.nih.gov/pubmed/29707241
http://dx.doi.org/10.1038/s41420-018-0049-2

Ejemplares similares